1. Catalog
  2. Course: Launch Excellence Best Practices for Medic ...
Image For Activity Cover
Course: Launch Excellence Best Practices for Medical Affairs
Medical Strategy and Launch Excellence Focus Area Working Group
Course description

Through this course you will:

  • Review the changing role of Medical Affairs and how it has become a strong strategic partner in product launch excellence
  • Gain insights into the components of launch excellence
  • Understand the value of a collaborative cross-functional launch team to support launch excellence
  • Identify processes, systems, and tools to support launch excellence
  • Implement mechanisms for monitoring launch progress and evaluating impact and value
  • Utilize templates to support launch excellence planning

At the end of the course, you will have the opportunity to take an exam to test your competencies on this topic. Learners who score 80% or above will receive a certificate of completion which you may download as a PDF.

Course Content
Title    Duration
Pre-assessment Quiz    10 questions
What is Launch Excellence?      5 minutes
Medical Affairs Launch Excellence​ Evolution and Future Landscape      5 minutes
Medical Affairs Launch Excellence Teams      5 minutes
The Medical Affairs’ Launch Excellence Process​    10 minutes
Medical Affairs Excellence Strategy: Your Brand Vision      5 minutes
New and Growing Visionary Role      5 minutes
Certification Exam    10 questions
Module Developers
MAPS is appreciative to the following MAPS members and other individuals who were instrumental in creating the course content.
Content Developer: Ramin Farhood, PharmD, MBA


Ramin is Vice President of Medical Affairs Practice at SSI Strategy. He is an enthusiastic Sr. Medical Executive and entrepreneur with over 20 years in developing business-aligned and patient-centric medical strategies and translating these into proven tactical execution via strategic R&D, payer evidence generation, & establishing registries, KOL engagements, advocacy development and establishing Early Access Programs (EAP), influential publications, behavior changing education and medical messaging.  He is a pragmatic leader with experience in building high-functioning medical team with a scalable model while driving excellence in operations in bringing novel therapies in rare disorders to the market. He has demonstrated success in start-ups, specialty pharmaceutics and large pharma and has leveraged his clinical and business in to effective solutions responsive to today’s dynamic healthcare and challenging access environment.   
Content Developer: Lobna Salem, MD, MSc, MBA

Lobna Picture

Dr. Salem is the Head of Medical Affairs, Developed Markets & JANZ, Viatris/Legal Entity. She has held difference cross-functional roles in medical affairs, clinical development, regulatory interactions and commercial functions. Previously as Chief Medical Officer at Pfizer, Lobna medically led multiple business development activities for Pfizer as well joint venture in multiple countries globally. She received multiple awards in recognition for her and her team’s efforts in improving patient outcome as well as recognized for driving innovation across Research and Development in Pfizer. Lobna is a hematologist by training; she received her Medical degree from Cairo University and MBA from Edinburgh business school UK and MSc from Hibernia Ireland. 



Content Developer: Paul W. Tebbey, PhD, MBA


Dr. Paul W. Tebbey has 25 years of healthcare experience across the biotechnology and pharmaceutical sectors. Dr. Tebbey received a PhD in Microbiology and Immunology from East Carolina University School of Medicine (Greenville, NC) where his research focused on T lymphocyte cell signalling, immunosuppression and transformation. Subsequent to his postdoctoral studies at Vanderbilt University (Nashville, TN), which focused on the regulation of gene expression, he then graduated with a MBA in Marketing from Rochester Institute of Technology (Rochester, NY). Dr. Tebbey’s research, development and launch experiences include therapeutic monoclonal antibodies (adalimumab, infliximab and ustekinumab) & antibody-drug conjugates, oncolytics (venetoclax) as well as complex vaccines (conjugated pneumococcal vaccine). Dr. Tebbey’s publications include over 40 peer-reviewed articles that span immunology, immune-mediated and infectious diseases, as well as pharmaceutical publication planning and brand success.
Content Developer: Anna Walz



Anna Walz is a 25-year veteran in the pharmaceutical industry. She is the CEO of MedEvoke, which she founded in 1999. MedEvoke is dedicated to working with Medical Affairs leaders to drive alignment through development of clear medical strategies that can be globally communicated, measured, and analyzed. This has, for the first time, enabled Medial Affairs to track the impact of internal efforts on the external scientific and digital exchanges. Anna, who often speaks on the topics of medical strategy, launch excellence, impact metrics for medical affairs, female entrepreneurship, and diversity in the biosciences, is also a regular guest-lecturer on the topic of Pharmacology & Drug Marketing at the Rutgers Medical School. Anna has been one of the most vocal champions for MAPS since its inception, has served as Co-Chair of the Standards & Guidance Committee, and is currently serving as a member of the MAPS Board of Directors, the Fund Development Committee and the Learning & Development Committee. 

Contributor: Barbara Zolli

 

Barbara is Vice President, Content Services at MedEvoke and provided editorial support on the eLearning Module development.

Contributor: Rich Miller


Rich is the Chief Creative Officer at MedEvoke and provided creative support on the eLearning Module development.

Contributor: Keli Burd


Keli is Senior Director, Operations & Project Management at MedEvoke and provided project management support on the eLearning Module development.

Contributor: Kacie Corbitt

Kacie is a Project Manager at MedEvoke and provided project management support on the eLearning Module development.
Summary
Availability: On-Demand
Cost: Member: $0.00
Non-Member: $135.00
Create Account
Recommended
Powered By